ReviewReviews in endocrine & metabolic disorders2022

A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.

Vanita R Aroda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.